Showing results (11-20 of 124) with videos related to
Sort By:
Pageof 13
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 13, 2009
Predictive modelling in hormone-refractory prostate cancer (HRPC)J Bellmunt, J Carles, J AlbanellCritical Reviews in Oncology/Hematology|August 30, 2008
Prostate cancer. Multidisciplinary approach: a key to successC Montagut, J Albanell, J BellmuntCritical Reviews in Oncology/Hematology|July 10, 2003
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor familyJ Bellmunt, M Hussain, C P DinneyEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1989
Fatal septic thrombophlebitis due to Salmonella enteritidisM Navarro, B Almirante, J Bellmunt, et al.Journal of Surgical Oncology|August 1, 1996
Endobronchial metastatic disease: analysis of 32 casesA Salud, J M Porcel, A Rovirosa, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclinesJ Bellmunt, S Morales, M Navarro, et al.Tumori|June 30, 1988
Palmar-plantar erythrodysesthesia syndrome associated with short-term continuous infusion (5 days) of 5-fluorouracilJ Bellmunt, M Navarro, R Hidalgo, et al.Medical Hypotheses|March 1, 1993
Mechanisms of glycation in atherogenesisR Pamplona, M J Bellmunt, M Portero, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2014
New agents for prostate cancerN Agarwal, G Di Lorenzo, G Sonpavde, et al.European Journal of Cancer (Oxford, England : 1990)|October 26, 2001
A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancerJ Bellmunt, R de Wit, J Albanell, et al.Pageof 13